Thomas Höhler
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Immunology top 2%
- Immunotherapy and Immune Responses
- Psoriasis: Treatment and Pathogenesis
Papers in
- Hepatology 18
- Hepatitis C virus research 13
- Hematology 13
- Autoimmune and Inflammatory Disorders Research 6
- Co-authors
- Peter R. GalleChristian RittnerPeter M. SchneiderMoritz KochJürgen DebusJürgen WeitzMarkus W. BüchlerAnke Krüger
- Journals
- Annals of Oncology (7 papers)Journal of Hepatology (5 papers)Genes and Immunity (4 papers)Annals of the Rheumatic Diseases (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- GermanySpainUnited States
In The Last Decade
Thomas Höhler
73 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Hepatology 810
- Immunology 935
- Oncology 1.0k
- Rheumatology 464
- Epidemiology 997
Countries citing papers authored by Thomas Höhler
This map shows the geographic impact of Thomas Höhler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Höhler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Höhler more than expected).
Fields of papers citing papers by Thomas Höhler
This network shows the impact of papers produced by Thomas Höhler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Höhler. The network helps show where Thomas Höhler may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Höhler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 1 | |
| 2 | 2016 | 61 | |
| 3 | 2016 | 1 | |
| 4 | 2014 | 89 | |
| 5 | 2014 | 5 | |
| 6 | 2010 | 2 | |
| 7 | Cetuximab with irinotecan/NA-FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomised multi-centre AIO phase II study | 2008 | 8 |
| 8 | 2008 | 45 | |
| 9 | 2007 | 1 | |
| 10 | 2006 | 63 | |
| 11 | 2005 | 29 | |
| 12 | 2004 | 30 | |
| 13 | 2002 | 213 | |
| 14 | 2002 | 161 | |
| 15 | 2001 | 4 | |
| 16 | 1999 | 2 | |
| 17 | 1999 | 13 | |
| 18 | 1999 | 16 | |
| 19 | 1998 | 16 | |
| 20 | 1998 | 133 |
About Thomas Höhler
Thomas Höhler is a scholar working on Hepatology, Hematology, Rheumatology, Immunology and Oncology, having authored 76 papers that have together received 3.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (13 papers), Spondyloarthritis Studies and Treatments (10 papers), Gastric Cancer Management and Outcomes (9 papers), Systemic Lupus Erythematosus Research (7 papers), Cancer Treatment and Pharmacology (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). The work is most often cited by research in Hepatology (810 citations), Immunology (935 citations), Oncology (1.0k citations), Rheumatology (464 citations) and Epidemiology (997 citations). Thomas Höhler has collaborated with scholars based in Germany, Spain and United States. Frequent co-authors include Peter R. Galle, Christian Rittner, Peter M. Schneider, Moritz Koch, Jürgen Debus, Jürgen Weitz, Markus W. Büchler, Anke Krüger, Guido Gerken and Karl‐H. Meyer zum Büschenfelde. Their work appears in journals such as Annals of Oncology, Journal of Hepatology, Genes and Immunity, Annals of the Rheumatic Diseases and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.